Precigen (PGEN) EBITDA Margin (2012 - 2026)
Precigen (PGEN) posted EBITDA Margin of 43.19% for Q2 2026, up 3680.34 percentage points from -3637.15% a year earlier and up 64.24 percentage points from the prior quarter.
Precigen (PGEN) EBITDA Margin (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Precigen was -41.25%, up 2298.47 percentage points year-over-year; for FY2025, it came in at -1108.10%, up 2216.82 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of -1052.92 percentage points (FY2020 to FY2025).
- In prior years, Precigen's EBITDA Margin was -3324.92% in FY2024 (-1829.50 pp), -1495.42% in FY2023 (-1254.01 pp), -241.41% in FY2022 (+306.62 pp) and -548.03% in FY2021 (-492.85 pp).
- The Q2 2026 figure stands as the highest quarterly EBITDA Margin in data going back to Q2 2012.
- On a year-over-year basis, EBITDA Margin has increased in each of the last seven quarters, with an average year-over-year change of +1609.90 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q2 2025, with a gain of 4625.75 percentage points; the weakest was Q2 2024, with a drop of 7163.47 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -21.05% (Q1 2026), -449.70% (Q4 2025) and -1152.57% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Precigen | 2.80 Bn | 2.80 Bn | 52.17 Mn | 43.19% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.19% |
| Mar 31, 2026 | -21.05% |
| Dec 31, 2025 | -449.70% |
| Sep 30, 2025 | -1,152.57% |
| Jun 30, 2025 | -3,637.15% |
| Mar 31, 2025 | -1,638.11% |
| Dec 31, 2024 | -2,340.76% |
| Sep 30, 2024 | -2,160.34% |
| Jun 30, 2024 | -8,262.90% |
| Mar 31, 2024 | -2,142.25% |
| Dec 31, 2023 | -2,655.54% |
| Sep 30, 2023 | -1,398.62% |
| Jun 30, 2023 | -1,099.43% |
| Mar 31, 2023 | -1,175.96% |
| Dec 31, 2022 | -1,138.74% |
| Sep 30, 2022 | -30.43% |
| Jun 30, 2022 | -719.20% |
| Mar 31, 2022 | -342.12% |
| Dec 31, 2021 | -503.61% |
| Sep 30, 2021 | -543.98% |
Precigen EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PGEN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "PGEN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PGEN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();